ArticleKidney medicine2025

Tolvaptan and Autosomal Dominant Polycystic Kidney Disease Progression in Individuals Aged 18-35 Years: A Pooled Database Analysis.

Fouad T Chebib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.